We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » California’s Ban on Brand-Name Drug Coupons Didn’t Lead to Big Increase in Generic Substitution, Study Finds
California’s Ban on Brand-Name Drug Coupons Didn’t Lead to Big Increase in Generic Substitution, Study Finds
A 2017 California law banning the use of co-payment coupons for brand-name drugs with direct generic competitors was associated with no significant increase in generic substitution in its first year.